Federal grants to Parmedics, Inc
Parmedics, Inc in Temecula, California received $2.6 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Cardiovascular Diseases Research, with $2.3 million. In fiscal 2025 it was awarded $792,665.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$2.6 million
- Awards4
- Awarded in FY 2025$792,665
- Largest award$1.7 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $283,387 |
| FY 2022 | 0 | $0 |
| FY 2023 | 2 | $610,351 |
| FY 2024 | 1 | $878,390 |
| FY 2025 | 1 | $792,665 |
Programs that fund Parmedics, Inc
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 3 | $2.3 million |
| Drug Use and Addiction Research Programs | 1 | $310,351 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $2.6 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Pharmacokinetic and efficacy studies of the aerosolized PAR2 antagonist, C781, for the treatment of asthma - project summary current treatments for asthma are largely aimed at reducing the incidence of exacerbations with inhaled drugs that inhibit general inflammation, e.g., corticosteroids. While s | Cardiovascular Diseases Research | March 6, 2024 | $1.7 million |
| PROTEASE-ACTIVATED-RECEPTOR-2 antagonists for treatment of migraine pain - project summary migraine affects over 36 million people in the us, particularly those of working age (18-55 years), negatively impacting workplace productivity and presenting an enormous healthcare burden. For almost half of | Drug Use and Addiction Research Programs | February 24, 2023 | $310,351 |
| Development of small molecule PROTEASE-ACTIVATED-RECEPTOR-2 antagonists as oral asthma therapeutics - lay abstract: asthma is a widely prevalent condition that affects 1 in 12 adults in the united states and an estimated 300 million individuals worldwide. Mild asthma is well controlled by current st | Cardiovascular Diseases Research | September 14, 2023 | $300,000 |
| Development of small molecule antagonists of PAR-2 for treatment of asthma - abstract: current treatments for asthma largely are aimed at reducing exacerbations by directly treating airway inflammation. While successful in a subset of patients, asthma exacerbations remain a significant cause of morb | Cardiovascular Diseases Research | September 1, 2021 | $283,387 |
Questions people ask
How much federal grant money does Parmedics, Inc get?
$2.6 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Parmedics, Inc the most?
The Department of Health and Human Services, with $2.6 million in 4 awards.
What is Parmedics, Inc's largest federal grant?
$1.7 million under Cardiovascular Diseases Research, with its first action in the period on March 6, 2024. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Parmedics, Inc?
Its largest are Cardiovascular Diseases Research and Drug Use and Addiction Research Programs.
Other grant recipients in Temecula
- All Mission Indian Housing Authority
- Center for Natural Lands Management
- Rancho California Water District
- Pechanga Band of Luiseno Indians
- City of Temecula
Largest federal grant recipients in California · Federal grants in California